Organon & Co.
For the period ended Dec 31, 2025. Filed Feb 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 24, 2026
OGN$13.85-0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Balance Sheets
($ in millions except shares in thousands and per share amounts)
| December 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash and cash equivalents | $574 | $675 |
| Accounts receivable (net of allowance for doubtful accounts of $12 in 2025 and $14 in 2024) | 1,331 | 1,358 |
| Inventories (excludes inventories of $236 in 2025 and $215 in 2024 classified in Other assets) | 1,406 | 1,321 |
| Other current assets | 1,033 | 994 |
| Assets held for sale | 8 | — |
| Total Current Assets | 4,352 | 4,348 |
| Property, plant and equipment, net | 1,303 | 1,168 |
| Goodwill | 4,153 | 4,680 |
| Intangibles, net | 1,130 | 1,414 |
| Other assets | 1,539 | 1,491 |
| Noncurrent assets held for sale | 390 | — |
| Total Assets | $12,867 | $13,101 |
| Liabilities and Equity | ||
| Current Liabilities: | ||
| Current portion of long-term debt and short-term borrowings | $16 | $20 |
| Trade accounts payable | 952 | 1,153 |
| Accrued and other current liabilities | 1,335 | 1,411 |
| Income taxes payable | 85 | 134 |
| Liabilities held for sale | 2 | — |
| Total Current Liabilities | 2,390 | 2,718 |
| Long-term debt | 8,628 | 8,860 |
| Deferred income taxes | 57 | 74 |
| Other noncurrent liabilities | 1,008 | 977 |
| Noncurrent liabilities held for sale | 32 | — |
| Total Liabilities | 12,115 | 12,629 |
| Contingencies (Note 18) | ||
| Organon & Co. Stockholders’ Equity: | ||
| Common stock, $0.01 par valueAuthorized - 500,000Issued and outstanding - 260,316 in 2025 and 257,799 in 2024 | 3 | 3 |
| Additional paid-in capital | 167 | 108 |
| Retained earnings | 1,109 | 1,010 |
| Accumulated other comprehensive loss | (527) | (649) |
| Total Stockholders’ Equity | 752 | 472 |
| Total Liabilities and Stockholders’ Equity | $12,867 | $13,101 |
-64-
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.